John Sourbeer
Stock Analyst at UBS
(0)
# 4797
Out of 5,370 analysts
51
Total ratings
30.77%
Success rate
-18.79%
Average return
Main Sectors:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
CYRX CryoPort | Maintains: Strong Buy | 10 11 | 6.91 | 59.19% | 6 | Apr 1, 2025 | |
STVN Stevanato Group | Maintains: Neutral | 24 24 | 24.05 | -2.29% | 2 | Mar 7, 2025 | |
QDEL QuidelOrtho | Maintains: Neutral | 43 45 | 29.24 | 53.9% | 3 | Feb 13, 2025 | |
QGEN Qiagen | Maintains: Neutral | 50 48 | 47.42 | 1.22% | 4 | Feb 7, 2025 | |
WST West Pharmaceutical ... | Upgrades: Buy | 350 390 | 224.09 | 74.04% | 3 | Dec 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 2 | 1.38 | 44.93% | 3 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 133 145 | 90.09 | 60.95% | 3 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 12 15 | n/a | n/a | 2 | Mar 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 452 480 | 300.75 | 59.6% | 4 | Mar 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 7 8 | 1.27 | 490.55% | 2 | Mar 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 94 102 | 39.02 | 161.4% | 3 | Mar 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 58 64 | n/a | n/a | 6 | Feb 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 7 3 | n/a | n/a | 2 | Oct 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Neutral | 50 | 11.03 | 353.31% | 1 | Feb 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Neutral | 68 | n/a | n/a | 1 | Sep 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 270 | 146.97 | 83.71% | 1 | Sep 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 142 128 | 133.99 | -4.47% | 2 | Jul 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 13 4 | n/a | n/a | 2 | Mar 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 23 | n/a | n/a | 1 | Feb 22, 2021 |